The global peptide synthesis market size is expected to reach USD 1,011.99 million by 2026 growing at a CAGR of 13.0%, according to a new report by Grand View Research, Inc. Significant research and innovation targeted towards the development of peptide therapeutics is set to boost the market growth in the near future. Additionally, increasing advancements in the peptide synthesis technologies is expected to offer profitable opportunities for the companies operating in the market.
A
surge in the demand for custom peptide synthesis has been observed in the
recent years; several companies operating in this industry offer products and
services associated with custom peptide synthesis. For instance, a UK based
company namely, Almac Group offers peptide synthesis suitable for research use.
Constantly growing demand and evolving market landscape for custom peptides is
set to offer lucrative opportunities for the market growth. The suppliers are
expanding their production capacity to suffice the increasing demand for high
quality peptides across research and therapeutics areas.
Rising
focus of the pharmaceutical companies towards the development of novel
biologics and shifting the peptide drugs from the pipeline stage to commercial
scale further strengthens the market growth. Increase in the number of research
activities performed on exploring the potential of high-quality peptides and
peptide libraries in the development of vaccines and biomarker discovery
heavily contributes to the revenue generated by the global peptide synthesis
market. Moreover, introduction of modified peptides (GMP peptides) that possess
enhanced stability and pharmacokinetic properties in the market is expected to
maintain the double-digit market growth throughout the forecast period.
Therapeutic
peptide development has witnessed remarkable growth in the recent years, this
is further driven by significant increase in the patient pool suffering from
cardiovascular and metabolic diseases. This has propelled the discovery of
bioactive peptides exponentially which further drives the market demand.
For more info visit here: https://www.grandviewresearch.com/industry-analysis/peptide-synthesis-market
Further key
findings from the study suggest:
- Reagents
& consumables accounted for the highest revenue generated in 2018 and
is anticipated to maintain this trend throughout the forecast period.
- Peptide
synthesis equipment has registered fastest growth during the forecast
period.
- Peptide
synthesizers segment serves to be a major contributor to the revenue
generated by equipment in the global market and is anticipated to grow at
highest CAGR of 13.91% from 2019-2026 among other peptide synthesis
equipment.
- Liquid phase
peptide synthesis (LPPS) technology dominated the peptide synthesis market
in 2018 and is expected to continue this dominance throughout the forecast
period.
- Therapeutic
peptide synthesis has garnered largest share in the market in 2018 and is
anticipated to maintain this trend throughout the forecast period.
- North America
region has generated highest revenue in 2018 and is expected to maintain
this dominance throughout the forecast period; sufficient presence of
skilled professionals along with the strong network of peptide synthesis
manufacturers is attributive to this region’s dominance in the global
market.
- APAC is
expected to offer lucrative opportunities for the market expansion,
attributed to rising focus on the development of peptide therapeutics.
- Large patient
pool for cardiovascular and metabolic diseases in the APAC region has
significantly contributed to the revenue generated, contributing to the
highest CAGR registered during the forecast period.
- Some of the
key market participants are Genscript Biotech, Merck KGaA, Bachem
Holdings, Biotage, CEM Corporation, Thermo Fisher, and Novo Nordisk among
others.
Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/peptide-synthesis-market/request/rs1
Grand View Research has
segmented the global peptide synthesis market on the basis of product,
technology, application, end-use, and region:
Peptide Synthesis
Product Outlook (Revenue, USD Million, 2014 - 2026)
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- Others
- Reagents & Consumables
- Other
Peptide Synthesis
Technology Outlook (Revenue, USD Million, 2014 - 2026)
- Solid Phase Peptide Synthesis (SPPS)
- Liquid Phase Peptide Synthesis (LPPS)
- Hybrid Technology
Peptide Synthesis
Application Outlook (Revenue, USD Million, 2014 - 2026)
- Therapeutics
- Cancer
- Metabolic
- Cardiovascular Disorder
- Respiratory
- GIT (Gastrointestinal Disorders)
- Infectious Diseases
- Pain
- Dermatology
- CNS
- Renal
- Others
- Diagnosis
- Research
Peptide Synthesis
End-use Outlook (Revenue, USD Million, 2014 - 2026)
- Pharmaceutical & Biotechnology Companies
- Contract Development & Manufacturing
Organization/Contract Research Organization
- Academic & Research Institutes
Peptide Synthesis
Regional Outlook (Revenue, USD Million, 2014 - 2026)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Asia Pacific
- Japan
- China
- India
- Australia
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
- Saudi Arabia
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment